The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement
Open accessThe DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Abstract
Tuberculosis (TB) is a possible complication of solid organ and hematopoietic stem cell transplantation. The identification of candidates for preventive chemotherapy is an effective intervention to protect transplant recipients with latent infection with Mycobacterium tuberculosis from progressing to active disease. The best available proxy for diagnosing latent infection with M. tuberculosis is the identification of an adaptive immune response by the tuberculin skin test or an interferon-γ based ex vivo assay. Risk assessment in transplant recipients for the development of TB depends on, among other factors, the locally expected underlying prevalence of infection with M. tuberculosis in the target population. In areas of high prevalence, preventive chemotherapy for all transplant recipients may be justified without immunodiagnostic testing while in areas of medium and low prevalence, preventive chemotherapy should only be offered to candidates with positive M. tuberculosis-specific immune responses. The diagnosis of TB in transplant recipients can be challenging. Treatment of TB is often difficult due to substantial interactions between anti-TB drugs and immunosuppressive medications. This management guideline summarises current knowledge on the prevention, diagnosis and treatment of TB related to solid organ and hematopoietic stem cell transplantation and provides an expert consensus on questions where scientific evidence is still lacking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
Flynn, J. L., & Chan, J. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 2,155
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Kasiske, B. L., Zeier, M. G., Chapman, J. R., Craig, J. C., Ekberg, H., Garvey, C. A., Green, M. D., Jha, V., Josephson, M. A., Kiberd, B. A., et al. (2010) · Kidney International · doi:10.1038/ki.2009.377 · Cited by 1,735
Immunosuppressive Drugs for Kidney Transplantation
Halloran, P. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmra033540 · Cited by 1,555
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., & Young, D. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,422
Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update
Pai, M., Zwerling, A., & Menzies, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00241 · Cited by 1,339
Global tuberculosis control 2010
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,262
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_3.ats600 · Cited by 1,241
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W., Gray, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,013
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Sterling, T. R., Villarino, M. E., Borisov, A. S., Shang, N., Gordin, F., Bliven-Sizemore, E., Hackman, J., Hamilton, C. D., Menzies, D., Kerrigan, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104875 · Cited by 977
Specific immune-based diagnosis of tuberculosis
Andersen, P., Munk, M., Pollock, J., & Doherty, T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02742-2 · Cited by 924
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
(2016) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610020190-part06-targeted · Cited by 920
Huebner, R. E., Schein, M. F., & Bass, J. B. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.6.968 · Cited by 917
THE PROGNOSIS OF A POSITIVE TUBERCULIN REACTION IN CHILDHOOD AND ADOLESCENCE
COMSTOCK, G. W., LIVESAY, V. T., & WOOLPERT, S. F. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121593 · Cited by 698
Mack, U., Migliori, G. B., Sester, M., Rieder, H. L., Ehlers, S., Goletti, D., Bossink, A., Magdorf, K., Hölscher, C., Kampmann, B., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00120908 · Cited by 591
Self-citationBest drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Caminero, J. A., Sotgiu, G., Zumla, A., & Migliori, G. B. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70139-0 · Cited by 574
Singh, N., & Paterson, D. L. (1998) · Clinical Infectious Diseases · doi:10.1086/514993 · Cited by 573
Diel, R., Goletti, D., Ferrara, G., Bothamley, G., Cirillo, D., Kampmann, B., Lange, C., Losi, M., Markova, R., Migliori, G. B., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00115110 · Cited by 544
Self-citationSester, M., Sotgiu, G., Lange, C., Giehl, C., Girardi, E., Migliori, G. B., Bossink, A., Dheda, K., Diel, R., Dominguez, J., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00114810 · Cited by 537
Self-citationMeasurement of Delayed Skin-Test Responses
Sokal, J. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197509042931013 · Cited by 500
(2000) · PubMed · Cited by 486
van Pittius, N. C. G., Sampson, S. L., Lee, H., Kim, Y., van Helden, P. D., & Warren, R. M. (2006) · BMC Evolutionary Biology · doi:10.1186/1471-2148-6-95 · Cited by 483
Newton, S. M., Brent, A. J., Anderson, S., Whittaker, E., & Kampmann, B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70182-8 · Cited by 480
Self-citationRangaka, M. X., Wilkinson, K. A., Glynn, J. R., Ling, D., Menzies, D., Mwansa-Kambafwile, J., Fielding, K., Wilkinson, R. J., & Pai, M. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70210-9 · Cited by 476
Voskuil, M. I., Visconti, K. C., & Schoolnik, G. K. (2004) · Tuberculosis · doi:10.1016/j.tube.2004.02.003 · Cited by 448 · cited 1×
“tuberculosis can survive for prolonged periods of time [15, 16].”
BackgroundIsoniazid for preventing tuberculosis in non-HIV infected persons
Smieja, M., Marchetti, C., Cook, D., & Smaill, F. M. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001363 · Cited by 434
Rapid Detection of Mycobacterium tuberculosis Infection by Enumeration of Antigen-specific T Cells
LALVANI, A., PATHAN, A. A., McSHANE, H., WILKINSON, R. J., LATIF, M., CONLON, C. P., PASVOL, G., & HILL, A. V. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.4.2009100 · Cited by 427
Harari, A., Rozot, V., Enders, F. B., Perreau, M., Stalder, J. M., Nicod, L. P., Cavassini, M., Calandra, T., Blanchet, C. L., Jaton, K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2299 · Cited by 387
Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation
Knoll, G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.051291 · Cited by 376
European Best Practice Guidelines for Renal Transplantation (Part 2).
Berthoux, F. C., Abramowicz, D., Ekberg, H., Frei, U. A., Morales, J., Ølgaard, K., Paul, L., & Pontecelli, C. (2002) · Lund University Publications (Lund University) · Cited by 371
Mycobacterium tuberculosis Infection in Recipients of Solid Organ Transplants
Munoz, P., Rodriguez, C., & Bouza, E. (2005) · Clinical Infectious Diseases · doi:10.1086/427692 · Cited by 357
Diel, R., Loddenkemper, R., Meywald-Walter, K., Niemann, S., & Nienhaus, A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1613oc · Cited by 351
Diagnosing Tuberculosis Infection in the 21st Century
Lalvani, A. (2007) · Chest · doi:10.1378/chest.06-2471 · Cited by 350
Aguado, J. M., Herrero, J. A., Gavald??, J., Torre-Cisneros, J., Blanes, M., Ruf??, G., Moreno, A., Gurgu??, M., Hayek, M., & Lumbreras, C. (1997) · Transplantation · doi:10.1097/00007890-199705150-00015 · Cited by 338
Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokines
Macdougall, I. C., & Cooper, A. C. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_11.39 · Cited by 336
Vaccination of hematopoietic cell transplant recipients
Ljungman, P., Cordonnier, C., Einsele, H., Englund, J., Machado, C. M., Storek, J., & Small, T. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.263 · Cited by 323
Self-citationLifetime Risks, Incubation Period, and Serial Interval of Tuberculosis
Vynnycky, E. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.3.247 · Cited by 322
Theron, G., Peter, J., van Zyl-Smit, R., Mishra, H., Streicher, E., Murray, S., Dawson, R., Whitelaw, A., Hoelscher, M., Sharma, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0056oc · Cited by 311
Torre‐Cisneros, J., Doblas, A., Aguado, J. M., San Juan, R., Blanes, M., Montejo, M., Cervera, C., Len, O., Carratala, J., Cisneros, J. M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/599035 · Cited by 298
Self-citationLeyten, E. M. S., Lin, M. Y., Franken, K. L. M. C., Friggen, A. H., Prins, C., van Meijgaarden, K. E., Voskuil, M. I., Weldingh, K., Andersen, P., Schoolnik, G. K., et al. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.03.018 · Cited by 269
Self-citationDorman, S. E., Johnson, J. L., Goldberg, S., Muzanye, G., Padayatchi, N., Bozeman, L., Heilig, C. M., Bernardo, J., Choudhri, S., Grosset, J. H., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0078oc · Cited by 264
Aguado, J. M., Torre‐Cisneros, J., Fortún, J., Benito, N., Meije, Y., Doblas, A., & Muñoz, P. (2009) · Clinical Infectious Diseases · doi:10.1086/597590 · Cited by 257
Self-citationAntituberculosis drugs and hepatotoxicity
YEW, W. W., & LEUNG, C. C. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00941.x · Cited by 256
SECTION IV: Long-term management of the transplant recipient
(2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_4.3 · Cited by 243
Marais, B. J., Gie, R. P., Schaaf, H. S., Hesseling, A. C., Obihara, C. C., Nelson, L. J., Enarson, D. A., Donald, P. R., & Beyers, N. (2004) · PubMed · Cited by 234
Lillebaek, T., Dirksen, A., Baess, I., Strunge, B., Thomsen, V. Ø., & Andersen, Å. B. (2002) · The Journal of Infectious Diseases · doi:10.1086/338342 · Cited by 234
Molecular aspects of T – and B-cell function in uremia
Girndt, M., Sester, M., Sester, U., Kaul, H., & Köhler, H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780206.x · Cited by 221
Self-citationHemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature
Karras, A., Thervet, E., & Legendre, C. (2004) · Transplantation · doi:10.1097/01.tp.0000107285.86939.37 · Cited by 207
Clinical manifestations of tuberculosis in children
Cruz, A. T., & Starke, J. R. (2007) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2007.04.008 · Cited by 204 · cited 1×
“Paediatric tuberculosis is most commonly a result of primary infection and therefore a previous history of tuberculosis is infrequently found in children who develop the disease following transplant [127, 130].”
BackgroundAdvances in the diagnosis of tuberculosis
LANGE, C., & MORI, T. (2010) · Respirology · doi:10.1111/j.1440-1843.2009.01692.x · Cited by 184
Self-citationEvaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
Ruhwald, M., Bodmer, T., Maier, C., Jepsen, M., Haaland, M. B., Eugen-Olsen, J., & Ravn, P. (2008) · European Respiratory Journal · doi:10.1183/09031936.00055508 · Cited by 184
Mycobacterium tuberculosisand the host response
Kaufmann, S. H. E., Cole, S. T., Mizrahi, V., Rubin, E. J., & Nathan, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050842 · Cited by 175
Millington, K. A., Fortune, S. M., Low, J., Garces, A., Hingley‐Wilson, S., Wickremasinghe, M. I. Y., Kon, O. M., & Lalvani, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015153108 · Cited by 170
Black, G. F., Thiel, B., Ota, M. O. C., Parida, S. K., Adegbola, R. A., Boom, W. H., Dockrell, H. M., Franken, K. L. M. C., Friggen, A. H., Hill, P. C., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00111-09 · Cited by 170
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
Kaufmann, S. H. E. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.015 · Cited by 166
Aichelburg, M. C., Rieger, A., Breitenecker, F., Pfistershammer, K., Tittes, J., Eltz, S., Aichelburg, A. C., Stingl, G., Makristathis, A., & Kohrgruber, N. (2009) · Clinical Infectious Diseases · doi:10.1086/597351 · Cited by 165
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy
Losi, M., Bossink, A. W. J., Codecasa, L. R., Jafari, C., Ernst, M., Thijsen, S. F. T., Cirillo, D. M., Ferrarese, M., Greinert, U., Fabbri, L. M., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00067307 · Cited by 159
Self-citationNew specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects
Nicol, M. P., & Zar, H. J. (2011) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2010.09.008 · Cited by 158
Holty, J.-E. C., Gould, M. K., Meinke, L., Keeffe, E. B., & Ruoss, S. J. (2009) · Liver Transplantation · doi:10.1002/lt.21709 · Cited by 146
The development of clinical tuberculosis following infection with tubercle bacilli
Sutherland, I., Svandova, E., & Radhakrishna, S. (1982) · Tubercle · doi:10.1016/s0041-3879(82)80013-5 · Cited by 144
Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients
Sun, H., & Singh, N. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832d7aff · Cited by 138
Genetic deficiencies of innate immune signalling in human infectious disease
van de Vosse, E., van Dissel, J. T., & Ottenhoff, T. H. M. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70255-5 · Cited by 136
Mycobacterium tuberculosis in Solid Organ Transplant Recipients
Subramanian, A. K., & Dorman, S. E. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02894.x · Cited by 128
Treatment of tuberculosis: update 2010
Yew, W. W., Lange, C. G., & Leung, C. C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00033010 · Cited by 123
Self-citationResponse to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Goletti, D., Butera, O., Vanini, V., Lauria, F., Lange, C. G., Franken, K. L. M. C., Angeletti, C., Ottenhoff, T. H. M., & Girardi, E. (2009) · European Respiratory Journal · doi:10.1183/09031936.00140009 · Cited by 122
Self-citationReconsidering Adjuvant Immunotherapy for Tuberculosis
Wallis, R. S. (2005) · Clinical Infectious Diseases · doi:10.1086/430914 · Cited by 121 · cited 1×
“Potential improvement could be obtained by new drug combinations including novel drugs such as the diarylquinoline TMC207 [167], or combinations with immunopotentiators [168, 169].”
BackgroundTreatment of latent infection with Mycobacterium tuberculosis: update 2010
Leung, C. C., Rieder, H. L., Lange, C., & Yew, W. W. (2011) · European Respiratory Journal · doi:10.1183/09031936.00079310 · Cited by 121
Self-citationManuel, O., Humar, A., Preiksaitis, J., Doucette, K., Shokoples, S., Peleg, A. Y., Cobos, I., & Kumar, D. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02011.x · Cited by 118
Th1 memory: implications for vaccine development
Foulds, K. E., Wu, C. Y., & Seder, R. A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00400.x · Cited by 118
Sester, M., Sester, U., Clauer, P., Heine, G. H., Mack, U., Moll, T., Sybrecht, G. W., Lalvani, A., & Köhler, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00586.x · Cited by 115
Self-citationde la Cámara, R., Martino, R., Granados, E., Rodriguez-Salvanés, F., Rovira, M., Cabrera, R., López, J., Parody, R., Sierra, J., Fernández-Rañada, J. M., et al. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702506 · Cited by 109
Kim, S. J., Lee, J. W., Jung, C. W., Min, C., Cho, B., Shin, H., Chung, J.-S., Kim, H., Lee, W. S., Joo, Y., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.026104 · Cited by 107
Kim, S., Lee, S.-O., Park, J. B., Park, I.-A., Park, S. J., Yun, S.-C., Jung, J. H., Kim, Y. H., Kim, S. C., Choi, S., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03625.x · Cited by 104
Tuberculosis in Renal Transplant Recipients: The Evidence for Prophylaxis
Currie, A., Knight, S. R., & Morris, P. J. (2010) · Transplantation · doi:10.1097/tp.0b013e3181ecea8d · Cited by 100
Thomas, M. M., Hinks, T., Raghuraman, S., Ramalingam, N., Ernst, M., Nau, R., Lange, C. G., Kösters, K., Gnanamuthu, C. P., John, G. T., et al. (2008) · PubMed · Cited by 97
Self-citationRenal Allograft Dysfunction Associated with Rifampin–Tacrolimus Interaction
Chenhsu, R.-Y., Loong, C.-C., Chou, M.-H., Lin, M.-F., & Yang, W.-C. (2000) · The Annals of Pharmacotherapy · doi:10.1345/1542-6270(2000)034<0027:radawr>2.3.co;2 · Cited by 96
Neue Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose
Diel, R., Loytved, G., Nienhaus, A., Castell, S., Detjen, A., Geerdes-Fenge, H. F., Haas, W. H., Hauer, B., Königstein, B., Maffei, D., et al. (2011) · Pneumologie · doi:10.1055/s-0030-1256439 · Cited by 93
Is IP-10 an Accurate Marker for Detecting M. tuberculosis-Specific Response in HIV-Infected Persons?
Goletti, D., Raja, A., Kabeer, B. S. A., Rodrigues, C. S., Sodha, A., Carrara, S., Vernet, G., Longuet, C., Ippolito, G., Thangaraj, S. K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012577 · Cited by 93
Self-citationMeyers, B. R., Papanicolaou, G. A., Sheiner, P., Emre, S., & Miller, C. (2000) · Transplantation · doi:10.1097/00007890-200001150-00013 · Cited by 83
Canet, E., Dantal, J., Blancho, G., Hourmant, M., & Coupel, S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr156 · Cited by 82
Tuberculosis drug development: Progress, challenges, and the road ahead
Ginsberg, A. M. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.03.003 · Cited by 81
IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy
Kabeer, B. S. A., Raja, A., Raman, B., Thangaraj, S. K., Leportier, M., Ippolito, G., Girardi, E., Lagrange, P. H., & Goletti, D. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-135 · Cited by 77
Self-citationSingh, N., Wagener, M. M., & Gayowski, T. (2002) · Transplantation · doi:10.1097/00007890-200209270-00029 · Cited by 77
Russo, R., Dulley, F. L., Suganuma, L. M., Silva, I. L. A. F. E., Shikanai‐Yasuda, M. A., & Costa, S. F. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.08.001 · Cited by 69
Vincenti, D., Carrara, S., Butera, O., Bizzoni, F., Casetti, R., Girardi, E., & Goletti, D. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03462.x · Cited by 68
Self-citationJahng, A. W., Tran, T., Bui, L., & Joyner, J. L. (2007) · Transplantation · doi:10.1097/01.tp.0000266578.45634.4f · Cited by 67
Fluoroquinolones for treating tuberculosis
Зиганшина, Л. Е., Vizel, A., & Squire, S. B. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004795.pub2 · Cited by 65
Fluoroquinolones for treating tuberculosis
Зиганшина, Л. Е., & Squire, S. B. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004795.pub3 · Cited by 64
Al-Sulaiman, M. H., Dhar, J. M., & AL-KHADER, A. A. (1990) · Transplantation · doi:10.1097/00007890-199010000-00014 · Cited by 58
Chiacchio, T., Petruccioli, E., Vanini, V., Butera, O., Cuzzi, G., Petrone, L., Matteucci, G., Lauria, F., Franken, K. L. M. C., Girardi, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027539 · Cited by 57
Self-citationNew tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response
Butera, O., Chiacchio, T., Carrara, S., Casetti, R., Vanini, V., Meraviglia, S., Guggino, G., Dieli, F., Vecchi, M., Lauria, F., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-182 · Cited by 57
Self-citationLou, H., Shullo, M. A., & McKaveney, T. P. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.9.701.34065 · Cited by 51
Multidrug-resistant tuberculosis in a lung transplant recipient
Lee, J. J., Yew, W. W., Wong, C. F., Wong, P. C., & Chiu, C. S. W. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)01189-0 · Cited by 51
Effect of Rifampicin on Cyclosporin A Blood Levels in a Renal Transplant Recipient
Cassidy, M. J., van Zyl-Smit, R., Pascoe, M. D., et al. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000183583 · Cited by 45
Haddad, H. A., Isaac, D., Légaré, J., Pflugfelder, P. W., HENDRY, P. J., Chan, M. C. Y., Cantin, B., Giannetti, N., Zieroth, S. R., White, M., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70061-3 · Cited by 40
Mycobacterial infections in organ transplant recipients
John, G. T. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.36445 · Cited by 38
Safety and Completion Rate of Short‐Course Therapy for Treatment of Latent Tuberculosis Infection
Cook, P., Maldonado, R. A., Yarnell, C. T., & Holbert, D. (2006) · Clinical Infectious Diseases · doi:10.1086/505398 · Cited by 38
Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose
Diel, R., Forßbohm, M., Loytved, G., Haas, W., Hauer, B., Maffei, D., Magdorf, K., Nienhaus, A., Rieder, H. L., Schaberg, T., et al. (2007) · Pneumologie · doi:10.1055/s-2007-959219 · Cited by 34
Self-citationPulmonary manifestations of the immune reconstitution inflammatory syndrome
Calligaro, G., Meintjes, G., & Mendelson, M. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328344f692 · Cited by 31
Multidrug resistant tuberculosis following lung transplantation: treatment with pulmonary resection.
Shitrit, D., Bendayan, D., Saute, M., & Kramer, M. R. (2004) · PubMed Central · Cited by 24
Fatal primary multidrug-resistant tuberculosis in a heart transplant recipient
Perri, G. D., Luzzati, R., Forni, A., Allegranzi, B., Cazzadori, A., Bonora, S., Mazzucco, A., & Concia, E. (1998) · Transplant International · doi:10.1007/s001470050147 · Cited by 24
Tomioka, H., Tatano, Y., Sano, C., & Shimizu, T. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0177-y · Cited by 23
Tuberculosis in Liver Transplant Recipients: Prophylaxis in an Endemic Area
Agoglia, L., Balbi, E., Halpern, M., Roma, J., Carius, L., Martinho, J. M., & Moreira, L. P. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.12.033 · Cited by 21
Drug interaction between rifampicin and sirolimus in transplant patients.
Ngo, B., Pascoe, M., & Khan, D. (2011) · PubMed · Cited by 20
Mycobacterium avium Complex Infection After Alemtuzumab Therapy for Chronic Lymphocytic Leukemia
Saadeh, C. E., & Srkalović, G. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.2.281 · Cited by 15
Cited by
Mycobacterial infections in solid organ transplant recipients
Meije, Y., Piersimoni, C., Torre-Cisneros, J., Dilektasli, A. G., & Aguado, J. M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12641 · Cited by 124
Metadata
- Authors
- Bumbacea, D., Arend, S. M., Eyuboglu, F., Fishman, J. A., Goletti, D., Ison, M. G., Jones, C. E., Kampmann, B., Kotton, C. N., Lange, C., Ljungman, P., Milburn, H., Morris, M. I., Muller, E., Muñoz, P., Nellore, A., Rieder, H. L., Sester, U., Theodoropoulos, N., Wagner, D., & Sester, M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2012-04-10
- Volume
- 40
- Issue
- 4
- Pages
- 990-1013
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2128339869
- Cited by
- 264
- References
- 118
- FWCI
- 10.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.